Integration of Alzheimer’s disease genetics and myeloid genomics identifies disease risk regulatory elements and genesGloriia Novikova, Alison Goate|Nature Communications|2021Cited by 230
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple SclerosisAinhoa Etxeberría, Christopher J. Bohlen, Allison Soung et al.|Journal of Neuroscience|2024Cited by 28
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen Schauer, Anne Biever, Chang Hoon Cho et al.|Alzheimer s & Dementia|2024Cited by 5